Trump Shifts Focus Back to Economic Sanctions in Iran War
President Donald Trump is pivoting back to sanctions as his strategy for ending the war in Iran, despite other approaches failing to yield results. The move comes after months of bombing have pushed Iran's economy to a breaking point, with inflation at an annual rate of 88.6% and average oil loadings decreased from 1.8 million barrels per day before the war to less than 500,000 barrels per day over the past month.
Trump claims that Iran is 'totally broke' and unable to pay its soldiers, but experts caution that sanctions have a limited impact when not accompanied by clear strategic goals. The U.S. Treasury Department's 'Operation Economic Fury' against Iran has been ongoing since April 16, with the goal of cutting off oil sales and banking transactions.
However, critics argue that the sanctions are unable to bite as quickly as the impact of the largely shuttered Strait of Hormuz, which has limited global supplies of gasoline and other forms of energy. The U.S. economy is also feeling the effects of the war, with elevated inflation and borrowing costs rising.
Trump's latest pivot to economic issues with Iran marks a flip-flop from his previous stance, as he had long derided past presidents who used sanctions to limit Iran's economic ability to pay for its military and nuclear development. The president insists that the pressure can lead to a breakthrough, but critics remain skeptical.
Richard Nephew, a senior research scholar at Columbia University, noted that 'economic pressure is a possible element in his strategy, but he's yet to explain the purpose.' Juan Zarate, a deputy national security adviser in the George W. Bush administration, argued that sanctions and the U.S. naval blockade of Iranian ports give the U.S. economic and financial leverage.
Esmaeil Baqaei, spokesman for Iran's Foreign Ministry, dismissed Trump's claims, saying 'Whenever Washington proves itself incapable of pursuing diplomacy, it retreats into sanctions; and whenever those sanctions fail to produce results, it simply increases the dose.'